Jazz Net Borrowings from 2010 to 2025

JAZZ Stock  USD 121.18  1.44  1.17%   
Jazz Pharmaceuticals Net Borrowings yearly trend continues to be fairly stable with very little volatility. Net Borrowings is likely to outpace its year average in 2025. Net Borrowings is the difference between the amount of new debt Jazz Pharmaceuticals PLC has taken on and the amount of debt it has paid off during a given period. View All Fundamentals
 
Net Borrowings  
First Reported
2012-06-30
Previous Quarter
-7.8 M
Current Value
-7.8 M
Quarterly Volatility
953.1 M
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 349.5 M, Other Operating Expenses of 3.9 B or Operating Income of 698.6 M, as well as many indicators such as Price To Sales Ratio of 2.22, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Net Borrowings Growth Pattern

Below is the plot of the Net Borrowings of Jazz Pharmaceuticals PLC over the last few years. It is the difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period. Jazz Pharmaceuticals' Net Borrowings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Borrowings10 Years Trend
Very volatile
   Net Borrowings   
       Timeline  

Jazz Net Borrowings Regression Statistics

Arithmetic Mean222,681,475
Geometric Mean278,570,846
Coefficient Of Variation490.04
Mean Deviation686,188,328
Median(33,387,000)
Standard Deviation1,091,229,041
Sample Variance1190780.8T
Range4.5B
R-Value(0.07)
Mean Square Error1268686T
R-Squared0.01
Significance0.78
Slope(17,159,088)
Total Sum of Squares17861712.3T

Jazz Net Borrowings History

2025-635.9 M
2024-669.3 M
2022-582 M
20213.9 B
2020591.8 M
2019-33.4 M
2018-32.1 M

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Net Borrowings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Borrowings-669.3 M-635.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.